A/Prof Edmund Chiong graduated with the degrees of Bachelor of Medicine and Surgery from the National University of Singapore (NUS) in 1995. He obtained postgraduate qualifications (Fellow of the Royal College of Surgeons of Edinburgh and Fellow of the Royal College of Surgeons In Ireland) in Surgery and completed his Urology specialist training in Singapore. A/Prof Chiong subsequently completed a two-year clinical fellowship program in Urologic Oncology at the University of Texas MD Anderson Cancer Center in Houston, Texas, USA. He is also certified by the Society of Urologic Oncology, USA.
A/Prof Chiong's subspecialty interests include managing and performing surgery for prostate cancers, bladder cancers, kidney cancers, testes cancers, penile cancers, and performing robotic surgery and prostate cancer high-dose rate brachytherapy. A/Prof Chiong also manages general urologic diseases and is a kidney transplant surgeon with the Ministry of Health's renal transplantation team. Apart from clinical practice, A/Prof Chiong is actively involved in both clinical and laboratory research. His research interests include diagnostic modalities and new therapies for bladder cancer (including immunotherapy, gene therapy and targeted therapy), prostate cancer and other urologic malignancies. He has minor interests in investigating urinary tract infections, and medical device innovation.
He is an investigator in a number of grant-funded, clinical and basic science research projects. He was conferred a PhD (NUS) for his thesis on targeted therapy for bladder cancer. He also runs a number of clinical trials in bladder and prostate cancer. A/Prof Chiong has received more than 35 academic and fellowship awards, authored or co-authored a number of papers in peer-reviewed journals, and have presented more than 350 lectures and abstracts at regional or international scientific meetings. He is also a reviewer for many leading international urology and cancer journals.
A/Prof Chiong is currently Chairman of the Chapter of Urologists (College of Surgeons), Academy of Medicine, Singapore, is Past President (2016-2018) and current Board of Trustees member of the Singapore Urological Association, and Chairman of the Examinations Committee for Urology and Board member, Residency Advisory Committee / Joint Committee on Specialist Training (JCST), Ministry of Health, Singapore. He is the Cluster Sub-Specialty Lead for Urology and Co-Chair of the Robotic Surgery Program Steering Committee (NRSPSC), at the National University Health System, Singapore. He is also the Deputy Chairman, Scientific Committee, Urological Association of Asia (UAA), a member of the American Urological Association, European Association of Urology and the American Society of Clinical Oncology.
